After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Earlier, Yahoo Finance discussed this stock as it revealed Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, PBYI falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Puma Biotechnology Inc is $313.96M. A total of 0.65 million shares were traded on the day, compared to an average of 462.65K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, PBYI has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 7 BUYs and 13 SELLs from insiders. Insiders purchased 189,000 shares during that period but sold 236,897.
In the most recent transaction, AUERBACH ALAN H sold 41,396 shares of PBYI for 4.49 per share on Jan 03. After the transaction, the President and CEO now owns 6,936,947 company shares. In a previous transaction on Jan 03, NOUGUES MAXIMO F sold 15,682 shares at 4.49 per share. PBYI shares that Chief Financial Officer owns now total 128,666.
Among the insiders who sold shares, Ludwig Jeffrey Jerome disposed of 12,956 shares on Jan 03 at a per-share price of $4.49. This resulted in the Chief Commercial Officer holding 99,970 shares of PBYI after the transaction. In another insider transaction, HUNT DOUGLAS M sold 8,358 shares at $4.49 per share on Jan 03. Company shares held by the insider now total 103,319.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for PBYI in the last 3 months, the mean price target is $4.67 with high estimates of $8.00 and low estimates of $2.00. In terms of 52-week highs and lows, PBYI has a high of $7.73 and a low of $2.13.
As of this writing, PBYI has an earnings estimate of $0.3 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.35 per share and a lower estimate of $0.27. The company reported an EPS of $0.05 in the last quarter, which was 400.00% higher than expectations of $0.01.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. PBYI’s latest balance sheet shows that the firm has $82.11M in Cash & Short Term Investments as of fiscal 2021. There were $116.64M in debt and $109.59M in liabilities at the time. Its Book Value Per Share was $0.81, while its Total Shareholder’s Equity was -$2.45M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PBYI is Buy with a score of 3.33.
